Navigation Links
FDA Advisers Back Anemia Drugs for Kidney Patients
Date:10/19/2010

risks with the patients and obtain signatures authorizing their use.

The FDA also requires certification and active, continuing enrollment in an educational program for all doctors prescribing ESAs to cancer patients.

The rules do not apply to people given ESAs for conditions other than cancer.

The decision to treat someone with chronic kidney disease with an ESA must be made patient-by-patient, Singh said. But one major factor is whether the patient requires dialysis, he said.

"Those who are on dialysis tend to have severe anemia," Singh said. "Those who are not on dialysis usually have anemia that is less severe."

Dr. Jeffrey S. Berns, professor of medicine and pediatrics at the University of Pennsylvania, agreed that use of an ESA must be decided case by case. But to him, the overall condition of a patient is more important in making the decision than whether the patient is on dialysis.

"To go to the extremes, if you have a 95-year-old in a wheelchair, I see no reason to treat," Berns told HealthDay last spring. "If you have a 32-year-old who is active and wants to remain so, I see no problem in using an ESA to get the hemoglobin up."

One reason why the meta-analysis found so many problems, Berns said, is that studies tend to have few young people in them. "It may be the much older patient populations that were studied," he said. "No matter what you did to them, you may not be able to show much improvement in quality of life."

More information

The U.S. Food and Drug Administration has more on ESAs.

-- HealthDay staff

SOURCES: Ajay K. Singh, M.D., associate professor, medicine, Harvard Medical School, and director, renal division and dialysis services, Brigham and Women's Hospital, Boston;
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. FDA Advisers Consider Approval of Genetically Modified Salmon
2. FDA Advisers Weigh Approval of Genetically Modified Salmon
3. FDA Advisers Divided on Whether to Ban Diet Drug Meridia
4. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
5. FDA to Broaden Disclosure on Advisers Conflicts of Interest
6. FDA Advisers Urge Stricter Regulation of Tanning Beds
7. Anemia Drugs Could Pose Threat to Some Kidney Patients
8. Stroke prevention study in children with sickle cell anemia, iron overload stopped early
9. OHSU joins forces with UO, Harvard to accelerate Fanconi anemia research
10. Anemia Drugs Hold Dangers for Kidney Patients
11. Anemia Harder to Treat in Black Children With Kidney Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Advisers Back Anemia Drugs for Kidney Patients
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... one in five infants in the United States annually ... several months after birth. Research into probiotic use for ... April 1, 2014 issue of the British Medical ... "Probiotics and Infant Colic," concluding that the use of ... did not reduce crying or fussing in infants ...
(Date:4/17/2014)... Boston University School of Medicine (BUSM) have discovered ... in an experimental model. The findings, reported in ... Abuse , may lead to more effective treatments ... one of the leading causes of illness and ... economic impact by limiting the productivity of workers ...
(Date:4/17/2014)... (SACRAMENTO, Calif.) An international team led by researchers ... protein complex, which plays a key role in cell ... process. This is the first time the complex has ... could make cyclin B1/Cdk1 an excellent target to control ... medicine. The research was published online today in the ...
(Date:4/17/2014)... by Cesar A. Arias, M.D., Ph.D., at The University ... identified a new superbug that caused a bloodstream infection ... April 17 issue of The New England Journal ... of a class of highly-resistant bacteria known as methicillin-resistant ... major cause of hospital and community-associated infections. The superbug ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2
... 12 June 2009: After five years of receiving infliximab ... (AS) showed substantial clinical benefit (ASAS40, ASsessment in AS, ... five years, 78.4% of AS patients had no arthritis ... between tendon and bone). Over this period, patients continued ...
... The board of directors of Abbott today declared a quarterly common dividend ... 342nd consecutive quarterly dividend to be paid by Abbott since 1924. ... at the close of business on July 15, 2009. , , ... an 11 percent increase earlier this year - and was again named ...
... CHICAGO, June 12 Germany remains an attractive investment,location ... states.,This is in large part due to the robust ... American investor interest in,Germany remains steady, as confirmed by ... success stories at the "How,Far East? Eastern Germany: The ...
... Medifast, Inc. (NYSE: MED ) today announced that ... Medifast Weight Control Centers. Earlier in the year, the Company ... and analyze the success of the model throughout the year. ... expanding its investment in this area. , , Despite ...
... Travelers Turn to InsureMyTrip.com for Coverage Protection and Information ... ,the scientific criteria for an influenza pandemic have been ... the A(H1N1) virus, commonly referred to as Swine Flu, ... http://www.newscom.com/cgi-bin/prnh/20070529/NETU076LOGO ) , , "Particularly in ...
... of the University of Southern California (USC) have identified ... to breakan occurrence that marks the first step in ... researchers with the clearest insight yet into why these ... chromosome, says principal investigator Michael R. Lieber, M.D., Ph.D., ...
Cached Medicine News:Health News:IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS 2Health News:IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS 3Health News:American Investors Highlight Successes in Eastern Germany 2Health News:Medifast, Inc. to Expand Investment in Corporate Medifast Weight Control Centers 2Health News:Medifast, Inc. to Expand Investment in Corporate Medifast Weight Control Centers 3Health News:World Health Organization Declares A(H1N1) Pandemic 2Health News:World Health Organization Declares A(H1N1) Pandemic 3Health News:USC researchers identify DNA mutation that occurs at beginning point of T-cell lymphoma 2
(Date:1/15/2014)... 15, 2014  Novation, the leading health care supply chain ... value-added reseller (VAR) national contracts that expand its portfolio ... at lower costs. These include manufacturer product and service ... assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... January 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ...
(Date:1/15/2014)... Inc. (Nasdaq: ECTE ) ("Echo"), a medical ... non-invasive, wireless continuous glucose monitoring system, today announced that ... CEO of Echo Therapeutics, will present at "TEN", Noble ... Mr. Doman will make a corporate presentation to ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... today announced that Tom Ryan , Chairman, President and CEO, and Per Lofberg , Executive Vice President ... Healthcare Conference on March 23, 2010 . The Company is scheduled to speak at approximately 9:00 a.m. ... ... , , ...
... Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) announced today that it ... June 3, 2010 , in Rockville, Maryland .  The record ... .  Only stockholders of record at the close of business on ... any adjournment thereof.  Vanda anticipates mailing its proxy statement in ...
Cached Medicine Technology:CVS Caremark to Present at the Barclays Capital 2010 Global Healthcare Conference 2CVS Caremark to Present at the Barclays Capital 2010 Global Healthcare Conference 3Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 11.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 6 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm....
Medicine Products: